9/26/2013 6:45:53 AM
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Leerink Swann Rare Disease Roundtable on Wednesday, October 2, 2013 at 2:00 p.m. ET at Le Parker Meridien Hotel in New York City.
A live audio webcast of the presentation will be available on the News & Investors section of the company’s website, www.alnylam.com. A replay of the presentation will be available on the Alnylam website within 48 hours after the event.
Help employers find you! Check out all the jobs and post your resume.
comments powered by